Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry
NCT04310644 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-02-04
Summary
We examine patients with different autonomic neuropathies and Ehlers Danlos syndromes compared to healthy controls at three different points over time (baseline, after 3 months and after 1.5 years) to gain knowledge about the course of this disease and understand its pathophysiology, with a focus on Small Fiber neuropathy. Moreover we will validate the german version of the Malmö POTS Score and establish an easy diagnostic scheme for patients in outpatient care.
Conditions
- Autonomic Neuropathy
- Ehlers-Danlos Syndrome Hypermobility Type
- Small Fiber Neuropathy
- Postural Tachycardia Syndrome
Interventions
- OTHER
-
No intervention planned, but all patients get our standart treatment
Patients are selected from clinical Routine and get our standart Treatment based on their disease
Sponsors & Collaborators
-
DLR German Aerospace Center
collaborator OTHER -
RWTH Aachen University
lead OTHER
Principal Investigators
-
Andrea Maier · University Hospital, Aachen
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-15
- Primary Completion
- 2028-09-15
- Completion
- 2029-09-15
Countries
- Germany
Study Locations
More Related Trials
-
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
NCT03751644 ·Status: COMPLETED ·Phase: NA
-
Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
NCT07121985 ·Status: NOT_YET_RECRUITING
-
Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility
NCT04121338 ·Status: COMPLETED ·Phase: PHASE1
-
The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies
NCT03864185 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT07188844 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Sacral Nerve Stimulation for Mild-to-Moderate or Refractory Rheumatoid Arthritis
NCT04821050 ·Status: UNKNOWN ·Phase: NA
-
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105 ·Status: RECRUITING
-
Long Term Extension Study For SPM-005 Participants
NCT01552538 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
NCT01655394 ·Status: UNKNOWN
-
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
NCT04535843 ·Status: RECRUITING
-
Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test
NCT03905161 ·Status: COMPLETED
-
STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)
NCT01585298 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
NCT03669588 ·Status: COMPLETED ·Phase: PHASE3
-
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
NCT07146425 ·Status: RECRUITING
-
AXER-204 in Participants With Chronic Spinal Cord Injury
NCT03989440 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3
NCT03401073 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT01017159 ·Status: COMPLETED ·Phase: PHASE2
-
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy
NCT00278629 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
NCT06298552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis
NCT02565576 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
NCT04295538 ·Status: COMPLETED ·Phase: PHASE2
-
A Registered Cohort Study of Immune-Mediated Neuropathies
NCT04292834 ·Status: UNKNOWN
-
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
NCT00268788 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy
NCT05592990 ·Status: COMPLETED ·Phase: PHASE2
-
Tongji NADs Cohort
NCT07333196 ·Status: NOT_YET_RECRUITING